News

class=”has-custom-orange-color has-text-color has-link-color has-proxima-nova-font-family has-medium-font-size wp-elements-e3536d6c91376bb31a61ea4c83163a6e” style=”font-style:normal;font-weight:600″>As per DelveInsight analysis in the stress urinary incontinence devices market, the growing demand for stress urinary incontinence is predominantly attributed to the increasing prevalence of stress urinary incontinence amongst women across the globe. Another prominent factor is the rising incidence of diabetes mellitus, obesity, and Parkinson’s disease, acting…

class=”has-custom-orange-color has-text-color has-link-color has-proxima-nova-font-family has-medium-font-size wp-elements-ad999bf0d43e4febd0b72225148867ba” style=”font-style:normal;font-weight:600″>Novel treatment could cure potentially dangerous condition for millions An estimated 20-30 million Europeans suffer from Gastroesophageal Reflux Disease every day. Symptoms include heartburn and regurgitation. At best uncomfortable and at worst a cause of oesophageal cancer, a novel treatment could bring relief to hundreds of millions worldwide. Many…

class=”has-custom-orange-color has-text-color has-link-color has-proxima-nova-font-family has-medium-font-size wp-elements-97870d9e3d72c64ac4dfd6a1cfe6b908″ style=”font-style:normal;font-weight:600″>The MedTech company was selected to receive funding in support of a first-to-market procedure to cure Gastroesophageal Reflux Disease (GERD) SAN DIEGO, Sept. 17, 2019 /PRNewswire/ — AscentX Medical, Inc., a U.S. medical technology company focused on the clinical development of globally-impactful least-invasive medical treatment procedures, has been selected for the SME…